These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 22579320)
21. UK MPs demand more stringent regulation of medical devices across Europe. Torjesen I BMJ; 2012 Oct; 345():e7350. PubMed ID: 23114251 [No Abstract] [Full Text] [Related]
22. Medical device preemption after Medtronic, Inc. v. Lohr. Neraas MB Food Drug Law J; 1996; 51(4):619-29. PubMed ID: 11797731 [No Abstract] [Full Text] [Related]
23. [Complications from silicone implants and other so-called inert materials]. Faure M Ann Dermatol Venereol; 1995; 122(6-7):455-9. PubMed ID: 8526432 [No Abstract] [Full Text] [Related]
24. Premarket approval and federal preemption of product liability claims in the wake of Medtronic, Inc. v. Lohr. Jarcho DG Food Drug Law J; 1996; 51(4):613-8. PubMed ID: 11797730 [No Abstract] [Full Text] [Related]
25. Silicone breast implants: implications for society and surgeons. Renwick SB Med J Aust; 1996 Sep; 165(6):338-41. PubMed ID: 8862336 [TBL] [Abstract][Full Text] [Related]
26. Allergy to silicone: is it real? Finegold I Compr Ther; 1996 Jun; 22(6):393-8. PubMed ID: 8814388 [No Abstract] [Full Text] [Related]
27. Silicone gel breast implants. Ludgate SM Br J Theatre Nurs; 1994 Feb; 3(11):25. PubMed ID: 8142689 [No Abstract] [Full Text] [Related]
28. Stricter device regulation needed--lessons from the past. The Lancet Lancet; 2012 Jun; 379(9835):2402. PubMed ID: 22748573 [No Abstract] [Full Text] [Related]
29. Gastroenterology-urology devices; effective date of requirement for premarket approval of the penile inflatable implant. Food and Drug Administration, HHS. Final rule. Fed Regist; 2000 Apr; 65(71):19650-8. PubMed ID: 11010632 [TBL] [Abstract][Full Text] [Related]
30. Tougher rules on breast implants in Europe: what will they mean? Cicchetti S; Santi PL Plast Reconstr Surg; 2004 Oct; 114(5):1343-4. PubMed ID: 15457065 [No Abstract] [Full Text] [Related]
31. Buyers taking silicon-gel breast implant ruling in stride. Barlow RD Hosp Mater Manage; 1992 Feb; 17(2):1, 10-1. PubMed ID: 10170917 [No Abstract] [Full Text] [Related]
32. Inclusion of training patients in US Food and Drug Administration premarket approval cardiovascular device studies. Chen CE; Dhruva SS; Bero LA; Redberg RF Arch Intern Med; 2011 Mar; 171(6):534-9. PubMed ID: 21098342 [TBL] [Abstract][Full Text] [Related]
33. The National Breast Implant Registry. O'Donnell M Br J Theatre Nurs; 1994 Feb; 3(11):24. PubMed ID: 8142688 [No Abstract] [Full Text] [Related]
34. Regulation of medical devices in the European Union. Chai J J Leg Med; 2000 Dec; 21(4):537-56. PubMed ID: 11194571 [No Abstract] [Full Text] [Related]
35. Pharmaceuticals and medical devices: medical devices. Year end issue brief. Tiffany S Issue Brief Health Policy Track Serv; 2008 Jan; ():1-19. PubMed ID: 18345548 [No Abstract] [Full Text] [Related]
36. On the need for greater regulation of medical devices. Lowe NJ J Cutan Laser Ther; 2000 Mar; 2(1):1-2. PubMed ID: 11446085 [No Abstract] [Full Text] [Related]
37. Update on breast implants. Rheinstein PH; Bagley GP Am Fam Physician; 1992 Feb; 45(2):472-3. PubMed ID: 1739038 [No Abstract] [Full Text] [Related]
38. Part II: Sealing holes in the safety net. Peterson ED; Hirshfeld JW; Ferguson TB; Kramer JM; Califf RM; Kessler LG Am Heart J; 2004 Jun; 147(6):985-90. PubMed ID: 15199344 [No Abstract] [Full Text] [Related]
39. The recent controversy over breast implants and their risks. Sturim HS R I Med; 1992 Mar; 75(3):145-6. PubMed ID: 1554910 [No Abstract] [Full Text] [Related]
40. Advocates call for FDA to take tougher stance on postmarket safety studies. Kuehn BM JAMA; 2011 Oct; 306(15):1639-40, 1642. PubMed ID: 22009087 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]